Scientist Solutions: International Life Science Community By Scientists For Scientists

Thanks to our sponsors who make this site possible

    

Scientist-Solutions

 



Google+

At Scientist Solutions we cherish our role as a trusted source of information for scientists.  We hope that our newly designed site will make it easier than ever for you to access everything we have to offer.   Things may have moved around a little, but rest assured that all the features you enjoyed on our old site (the forums, the protocols, the events, my bench space, blogs)  are still here.  

Our Discussion Forums

Scientist Solutions began as a discussion board for life scientists and that is still one of our core offerings.   If you are looking for the discussion forums, please click "The Forums"  from the navigation bar above or click here.

Protocols and SciEvents

Always on the look out for new ways to help scientists to help each other,  Scientist Solutions introduced a new protocols section and an events section to our site in the past year.   Both have been very popular.   If you haven't yet discovered these listings, we invite you to do so now. 

Our Protocol Finder provides an easily searchable database of protocols that you can use both to find a protocol you need or to share the protocols that you rely on.  Just click "Protocol Finder" from the navigation bar above, or click here.

Our SciEvents section is setting out to be the most comprehensive listing of conferences, seminars, classes and webinars for life scientists on the web.   Search events listings by date, topic or type of event.    You are most welcome to add your own events to our listing too.   Just click SciEvents from the navigation bar above, or click here.

My Bench SpaceMembership Management

Are you looking for how to log in or wondering what happened to your bench space?     On our new site, we have made it much easier for you to manage your account and profile.   After logging in (note that the log in area has moved down the page),  you will see your new member status panel on the right hand side of the home page and every page.    Look here for an overview of your member information and find easy access to your newly remodeled My Bench Space, where you'll be able to edit your account information and preferences and manage your public profile.   Just click "Go to My Bench Space" from your member status panel or click here.

Blogging

Notice that featured blogs are now presented on the home page just below this article.   To read all blogs, just click the "view more" link below the featured blogs.   To create your own blog, go to your My Bench Space pages and click on the "blogs" tab.  To get to My Bench Space, log in then click the "Go to My Bench Space" link in your member status panel (see above) or just click here

Give us your feedback

We understand that it takes a little adjustment time to get used to a new design.  We apologize for any temporary confusion, but hope that once you've familiarized yourself with the new design and features you will be very pleased.   Either way, we would love to hear what you think.  Please share your opinion by clicking the 'contact us'  link at the top right of any page and send us a note or click here.




Latest Member Blogs

Member
Total Posts: 1
6/14/2017
09:29PM
Member
Total Posts: 1
6/14/2017
02:18PM
Member
Total Posts: 1
6/13/2017
09:49AM




Science News Feeds

Click a source to select it and see feeds below

BioScience News
Pharmaceutical News
Biotechnology News
Today's Science News
This Week in Science
Science (Editorial)
Science Now
Nextwave
New York Times
BBC
Bioscreening
Journals
Journal of Biology
Nature
European Journal of Cell Biology
Virology Journal
Science
PNAS
Magazines
New Scientist
The Scientist
Pharmaceutical Business Review
Life Sciences World
Science News

Biotechnology - Google News
Google News
This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
NewLink Genetics (NLNK) & BIO-TECHNE (TECH) Head-To-Head Survey - Week Herald

Week Herald

NewLink Genetics (NLNK) & BIO-TECHNE (TECH) Head-To-Head Survey
Week Herald
About BIO-TECHNE. BIO-TECHNE logo Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical ...

and more »
Global and Chinese Recombinant Bovine Enterokinase (rEK) Market – 2016 – Biotechnology, Enzymes, Healthcare ... - MilTech

Global and Chinese Recombinant Bovine Enterokinase (rEK) Market – 2016 – Biotechnology, Enzymes, Healthcare ...
MilTech
The Global and Chinese Recombinant Bovine Enterokinase (rEK) Market – 2016 Report has been published. It provides updated in 2018 year analysis of industries from Biotechnology, Enzymes, Healthcare Markets. The 'Global and Chinese Recombinant Bovine ...

and more »
DL Carlson Investment Group Inc. Acquires 27182 Shares of iShares NASDAQ Biotechnology Index (IBB) - The Ledger Gazette

DL Carlson Investment Group Inc. Acquires 27182 Shares of iShares NASDAQ Biotechnology Index (IBB)
The Ledger Gazette
iShares NASDAQ Biotechnology Index logo D L Carlson Investment Group Inc. boosted its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 200.5% during the fourth quarter, according to its most recent Form 13F filing with the ...

and more »
Canada Orthopedic Biomaterials Market Through 2021 – Biomaterials, Biotechnology, Healthcare Industries - MilTech

Canada Orthopedic Biomaterials Market Through 2021 – Biomaterials, Biotechnology, Healthcare Industries
MilTech
The Canada Orthopedic Biomaterials Market Through 2021 Report has been published. It provides updated in 2018 year analysis of industries from Biomaterials, Biotechnology, Healthcare Markets. The market intelligence report provides critical market data ...

and more »
DL Carlson Investment Group Inc. Has $1.35 Million Stake in Repligen Co. (RGEN) - StockNewsTimes

DL Carlson Investment Group Inc. Has $1.35 Million Stake in Repligen Co. (RGEN)
StockNewsTimes
Repligen logo D L Carlson Investment Group Inc. reduced its stake in shares of Repligen Co. (NASDAQ:RGEN) by 5.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,134 shares of ...

Ligand Pharmaceuticals Inc. (LGND) Shares Bought by US Bancorp DE - StockNewsTimes

Ligand Pharmaceuticals Inc. (LGND) Shares Bought by US Bancorp DE
StockNewsTimes
The institutional investor owned 10,978 shares of the biotechnology company's stock after purchasing an additional 2,447 shares during the period. US Bancorp DE owned 0.05% of Ligand Pharmaceuticals worth $1,503,000 at the end of the most recent ...

and more »
Proficio Capital Partners LLC Acquires 6000 Shares of iShares NASDAQ Biotechnology Index (IBB) - StockNewsTimes

Proficio Capital Partners LLC Acquires 6000 Shares of iShares NASDAQ Biotechnology Index (IBB)
StockNewsTimes
iShares NASDAQ Biotechnology Index logo Proficio Capital Partners LLC grew its holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 181.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission ...

and more »
iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Proficio Capital Partners LLC - StockNewsTimes

iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Proficio Capital Partners LLC
StockNewsTimes
iShares NASDAQ Biotechnology Index logo Proficio Capital Partners LLC boosted its stake in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 181.8% during the fourth quarter, according to its most recent disclosure with the SEC. The ...

and more »
Eagle Asset Management Inc. Invests $28.92 Million in Puma Biotechnology Inc (PBYI) - Dispatch Tribunal

Eagle Asset Management Inc. Invests $28.92 Million in Puma Biotechnology Inc (PBYI)
Dispatch Tribunal
Puma Biotechnology logo Eagle Asset Management Inc. bought a new position in shares of Puma Biotechnology Inc (NASDAQ:PBYI) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC ...
Financial Newsletter - ZacksZacks
Puma Biotechnology, Inc. - PBYI - Stock Price Today - ZacksZacks
SEC FORM 4 - SEC.govSEC.gov

all 42 news articles »
Prothena (PRTA) Upgraded by Zacks Investment Research to “Hold” - StockNewsTimes

StockNewsTimes

Prothena (PRTA) Upgraded by Zacks Investment Research to “Hold”
StockNewsTimes
The biotechnology company reported ($1.24) earnings per share for the quarter, topping the Zacks' consensus estimate of ($1.48) by $0.24. The firm had revenue of $0.23 million for the quarter, compared to the consensus estimate of $0.27 million ...

and more »